Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-24 Purchase | 2022-06-27 9:28 pm | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 10,000 | $4.6284 | $46,284 | 38,000 (Indirect) | View |
| 2022-02-02 Purchase | 2022-02-04 08:30 am | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 5,000 | $9.74 | $48,700 | 28,000 (Indirect) | View |
| 2021-11-16 Purchase | 2021-11-18 7:00 pm | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 23,000 | $12.28 | $282,472 | 23,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-31 Tax Withholding | 2024-04-02 4:17 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 36,263 | $11.3 | 906,187 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 5:07 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 721,000 | $0 | 1,519,250 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-02 5:07 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 26,323 | $8.19 | 1,519,250 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-02 7:43 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 36,263 | $7.96 | 824,573 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 4:53 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 36,263 | $6.47 | 860,836 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 5:32 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 36,263 | $5.9001 | 897,099 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-08 5:10 pm | N/A N/A | CLARIVATE Plc | CLVT | SAHA SAURABH Director | 22,058 | $0 | 22,058 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:03 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 22,013 | $3.9 | 933,362 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:10 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 526,400 | $0 | 1,270,375 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 7:25 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 44,025 | $3.1 | 743,975 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 6:16 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 750,000 | $0 | 788,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 6:30 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 750,000 | $0 | 750,000 (Direct) | View |
Ownership | 2021-05-27 8:32 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer | 0 | $0 | 4,169,485 (Direct) | View |